Please login to the form below

Not currently logged in
Email:
Password:

Antabio bolsters leadership team

The French biopharma appoints four new executives

Antibacterial treatment focused biopharma Antabio has appointed four new executives to strengthen its leadership team.

Gordon Waldron, the firm’s current chairman of the board, heads up Antabio’s finance department on a part time basis.

He joins the biopharma from finance and business development advice firm Sequoia Business Solutions, where he was chief executive officer.

Joining Waldron is Carole Sable, who will oversee Antabio’s clinical strategy.

Sable, has worked for numerous pharmaceutical companies including Vitae Pharmaceuticals, Revolution Medicines and Merck.

She said: “It is exciting to have the opportunity to work on the development of Antabio’s MBLi, which addresses a significant unmet need.”

Leading the firm’s business development dealings is Helmuth van Es, who joins the biopharma from biotech Galapagos, where he was founder.

Furthermore, David Lathbury, who was previously director of process chemistry at AstraZeneca and vice president of chemical development at AMRI, will manage all of Antabio’s CMC activities.

Marc Lemonnier, chief executive officer of Antabio, said: “We are thrilled to have attracted such high calibre talent and these new additions, along with expertise already in house, give Antabio the broad skill sets and high quality international leadership team needed as we embark on the next phase of our growth and move our antibacterial resistance pipeline towards the clinic.”

15th January 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics